Zamaray B, van Velzen R A, Snaebjornsson P, Consten E C J, Tanis P J, van Westreenen H L
Department of Surgery, Isala, Zwolle, the Netherlands; Department of Surgery, University Medical Centre Groningen, Groningen, the Netherlands; Department of Surgery, Amsterdam UMC, Cancer Centre Amsterdam, University of Amsterdam, Amsterdam, the Netherlands.
Department of Surgery, Amsterdam UMC, Cancer Centre Amsterdam, University of Amsterdam, Amsterdam, the Netherlands.
Eur J Surg Oncol. 2023 Jan;49(1):1-8. doi: 10.1016/j.ejso.2022.08.008. Epub 2022 Aug 15.
Perforated colon cancer (PCC) is a distinct clinical entity with implications for treatment and prognosis, however data on PCC seems scarce. The aim of this systematic review is to provide a comprehensive overview of the recent literature on clinical outcomes of PCC.
A systematic literature search of MEDLINE (PubMed), Embase, Cochrane library and Google scholar was performed. Studies describing intentionally curative treatment for patients with PCC since 2010 were included. The main outcome measures consisted of short-term surgical complications and long-term oncological outcomes.
Eleven retrospective cohort studies were included, comprising a total of 2696 PCC patients. In these studies, various entities of PCC were defined. Comparative studies showed that PCC patients as compared to non-PCC patients have an increased risk of 30-day mortality (8-33% vs 3-5%), increased post-operative complications (33-56% vs 22-28%), worse overall survival (36-40% vs 48-65%) and worse disease-free survival (34-43% vs 50-73%). Two studies distinguished free-perforations from contained perforations, revealing that free-perforation is associated with significantly higher 30-day mortality (19-26% vs 0-10%), lower overall survival (24-28% vs 42-64%) and lower disease-free survival (15% vs 53%) as compared to contained perforations.
Data on PCC is scarce, with various PCC entities defined in the studies included. Heterogeneity of the study population, definition of PCC and outcome measures made pooling of the data impossible. In general, perforation, particularly free perforation, seems to be associated with a substantial negative effect on outcomes in colon cancer patients undergoing surgery. Better definition and description of the types of perforation in future studies is essential, as outcomes seem to differ between types of PCC and might require different treatment strategies.
穿孔性结肠癌(PCC)是一种独特的临床实体,对治疗和预后有影响,但关于PCC的数据似乎很少。本系统评价的目的是全面概述近期有关PCC临床结局的文献。
对MEDLINE(PubMed)、Embase、Cochrane图书馆和谷歌学术进行系统的文献检索。纳入自2010年以来描述对PCC患者进行意向性根治性治疗的研究。主要结局指标包括短期手术并发症和长期肿瘤学结局。
纳入11项回顾性队列研究,共2696例PCC患者。在这些研究中,定义了PCC的各种实体。比较研究表明,与非PCC患者相比,PCC患者30天死亡率增加(8-33%对3-5%),术后并发症增加(33-56%对22-28%),总生存率更差(36-40%对48-65%),无病生存率更差(34-43%对50-73%)。两项研究区分了游离穿孔和包裹性穿孔,结果显示与包裹性穿孔相比,游离穿孔与显著更高的30天死亡率(19-26%对0-10%)、更低的总生存率(24-28%对42-64%)和更低的无病生存率(15%对53%)相关。
关于PCC的数据很少,纳入的研究中定义了各种PCC实体。研究人群的异质性、PCC的定义和结局指标使得数据合并变得不可能。一般来说,穿孔,尤其是游离穿孔,似乎对接受手术的结肠癌患者的结局有重大负面影响。在未来的研究中,更好地定义和描述穿孔类型至关重要,因为不同类型的PCC结局似乎不同,可能需要不同的治疗策略。